Viridian Therapeutics, Inc.\DE (VRDN) Return on Capital Employed [ROCE] (2014 - 2026)
Viridian Therapeutics, Inc.\DE's Return on Capital Employed [ROCE] came in at -46.08% for Q2 2026, up 19.22 percentage points from -65.30% a year earlier and up 2.59 percentage points from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Viridian Therapeutics, Inc.\DE's Return on Capital Employed [ROCE] was -48.44%, up 4.16 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of +109.06 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -52.60% in FY2024 (+5.75 pp), -58.34% in FY2023 (-11.39 pp), -46.95% in FY2022 (+4.87 pp) and -51.82% in FY2021 (+105.67 pp).
- The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q4 2024.
- Year-over-year, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of +2.11 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2021 (a gain of 114.56 percentage points), and the weakest in Q4 2023 (a drop of 33.24 percentage points).
- Business Quant data shows VRDN's Return on Capital Employed [ROCE] at -48.67% (Q1 2026), -54.43% (Q4 2025) and -62.02% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - | -46.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.08% |
| Mar 31, 2026 | -48.67% |
| Dec 31, 2025 | -54.43% |
| Sep 30, 2025 | -62.02% |
| Jun 30, 2025 | -65.30% |
| Mar 31, 2025 | -50.45% |
| Dec 31, 2024 | -42.16% |
| Sep 30, 2024 | -44.40% |
| Jun 30, 2024 | -43.90% |
| Mar 31, 2024 | -44.52% |
| Dec 31, 2023 | -66.44% |
| Sep 30, 2023 | -73.23% |
| Jun 30, 2023 | -61.87% |
| Mar 31, 2023 | -47.44% |
| Dec 31, 2022 | -33.20% |
| Sep 30, 2022 | -40.83% |
| Jun 30, 2022 | -63.62% |
| Mar 31, 2022 | -48.65% |
| Dec 31, 2021 | -40.10% |
| Sep 30, 2021 | -90.91% |
API Access
Viridian Therapeutics, Inc.\DE Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();